Tags

Type your tag names separated by a space and hit enter

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
Clin Infect Dis. 2001 May 15; 32 Suppl 2:S81-93.CI

Abstract

The in vitro activities of numerous antimicrobials against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis from patients with bloodstream and respiratory tract infections in the United States, Canada, Europe, Latin America, and the Asia-Pacific region were studied in the SENTRY Antimicrobial Surveillance Program. Penicillin resistance (minimum inhibitory concentration, > or =2 microg/mL) was noted in all 5 geographic regions, and a high and increasing rate of macrolide resistance among S. pneumoniae isolates was observed. Elevated rates of resistance to clindamycin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline were seen. beta-Lactamase-mediated resistance in H. influenzae to amoxicillin and variable trimethoprim-sulfamethoxazole resistance by region were documented. Resistance to several drugs continues to emerge among pneumococci worldwide, but more stable resistance patterns have been noted for H. influenzae and M. catarrhalis. Continued surveillance of this pathogen group appears to be prudent.

Authors+Show Affiliations

Department of Clinical Microbiology, Health Sciences Centre, Winnipeg, Manitoba, Canada. dhoban@exchange.hsc.mb.caNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11320449

Citation

Hoban, D J., et al. "Worldwide Prevalence of Antimicrobial Resistance in Streptococcus Pneumoniae, Haemophilus Influenzae, and Moraxella Catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 32 Suppl 2, 2001, pp. S81-93.
Hoban DJ, Doern GV, Fluit AC, et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32 Suppl 2:S81-93.
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel-Delvallez, M., & Jones, R. N. (2001). Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 32 Suppl 2, S81-93.
Hoban DJ, et al. Worldwide Prevalence of Antimicrobial Resistance in Streptococcus Pneumoniae, Haemophilus Influenzae, and Moraxella Catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001 May 15;32 Suppl 2:S81-93. PubMed PMID: 11320449.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. AU - Hoban,D J, AU - Doern,G V, AU - Fluit,A C, AU - Roussel-Delvallez,M, AU - Jones,R N, PY - 2001/4/26/pubmed PY - 2001/8/10/medline PY - 2001/4/26/entrez SP - S81 EP - 93 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 32 Suppl 2 N2 - The in vitro activities of numerous antimicrobials against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis from patients with bloodstream and respiratory tract infections in the United States, Canada, Europe, Latin America, and the Asia-Pacific region were studied in the SENTRY Antimicrobial Surveillance Program. Penicillin resistance (minimum inhibitory concentration, > or =2 microg/mL) was noted in all 5 geographic regions, and a high and increasing rate of macrolide resistance among S. pneumoniae isolates was observed. Elevated rates of resistance to clindamycin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline were seen. beta-Lactamase-mediated resistance in H. influenzae to amoxicillin and variable trimethoprim-sulfamethoxazole resistance by region were documented. Resistance to several drugs continues to emerge among pneumococci worldwide, but more stable resistance patterns have been noted for H. influenzae and M. catarrhalis. Continued surveillance of this pathogen group appears to be prudent. SN - 1058-4838 UR - https://www.unboundmedicine.com/medline/citation/11320449/Worldwide_prevalence_of_antimicrobial_resistance_in_Streptococcus_pneumoniae_Haemophilus_influenzae_and_Moraxella_catarrhalis_in_the_SENTRY_Antimicrobial_Surveillance_Program_1997_1999_ L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/320181 DB - PRIME DP - Unbound Medicine ER -